BioMarin Pharmaceutical
BMRN
#1345
Rank
NZ$22.46 B
Marketcap
$117.75
Share price
-1.23%
Change (1 day)
-18.39%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): $1.27

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.36. In 2022 the company made an earnings per share (EPS) of $1.34 an increase over its 2021 EPS that were of -$0.61.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.27-5.07%
2022$1.34-319.62%
2021-$0.61-107.38%
2020$8.27-3485.71%
2019-$0.24-67.44%
2018-$0.75-34.85%
2017-$1.15-83.21%
2016-$6.86263.89%
2015-$1.8818.68%
2014-$1.59-28.91%
2013-$2.2334.74%
2012-$1.6693.88%
2011-$0.86-124.5%
2010$3.49
2009N/A-100%
2008$0.56-300%
2007-$0.28-54.29%
2006-$0.61-67.89%
2005-$1.90-62.54%
2004-$5.08136.59%
2003-$2.15-15.17%
2002-$2.53-11.59%
2001-$2.8656.19%
2000-$1.8310.53%
1999-$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.87-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.51-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.92-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.55 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.12-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.92 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA